These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17540983)

  • 1. New strategy for cardiac repair: genetically modified skeletal myoblasts.
    Sim EK; Ye L; Haider HKh
    Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):183-4. PubMed ID: 17540983
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically modified human myoblasts with eNOS may improve regenerative ability of myogenic stem cells to infarcted heart.
    Janeczek A; Zimna A; Rozwadowska N; Fraczek M; Kucharzewska P; Ruciński M; Mietkiewski T; Kolanowski T; Malcher A; Kurpisz M
    Kardiol Pol; 2013; 71(10):1048-58. PubMed ID: 24197586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic angiogenesis for peripheral artery disease: gene therapy.
    Nikol S
    Vasa; 2007 Aug; 36(3):165-73. PubMed ID: 18019272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor.
    Gmeiner M; Zimpfer D; Holfeld J; Seebacher G; Abraham D; Grimm M; Aharinejad S
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1238-45. PubMed ID: 21329947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic gene-modified myoblasts promote vascularization during repair of skeletal muscle defects.
    Zhou W; He DQ; Liu JY; Feng Y; Zhang XY; Hua CG; Tang XF
    J Tissue Eng Regen Med; 2015 Dec; 9(12):1404-16. PubMed ID: 23365046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of novel vascular endothelial growth factor gene delivery system manipulated skeletal myoblasts promote myocardial repair.
    Zhu K; Guo C; Xia Y; Lai H; Yang W; Wang Y; Song D; Wang C
    Int J Cardiol; 2013 Oct; 168(3):2622-31. PubMed ID: 23578891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as novel regulators of angiogenesis.
    Suárez Y; Sessa WC
    Circ Res; 2009 Feb; 104(4):442-54. PubMed ID: 19246688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.
    Guo M; Shi JH; Wang PL; Shi DZ
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell transplantation for heart disease: the clinical perspective.
    Yang S; Fazel S; Angoulvant D; Weisel RD; Li RK
    Evid Based Cardiovasc Med; 2005 Mar; 9(1):2-7. PubMed ID: 16379977
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor transgene expression in cell-transplanted hearts.
    Yau TM; Li G; Weisel RD; Reheman A; Jia ZQ; Mickle DA; Li RK
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1180-7. PubMed ID: 15052220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of human skeletal myoblasts genetically modified to simultaneously overexpress the pro-angiogenic factors vascular endothelial growth factor-A and fibroblast growth factor-4.
    Zimna A; Janeczek A; Rozwadowska N; Fraczek M; Kucharzewska P; Rucinski M; Mietkiewski T; Kurpisz M
    J Physiol Pharmacol; 2014 Apr; 65(2):193-207. PubMed ID: 24781729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold-based transplantation of vascular endothelial growth factor-overexpressing stem cells leads to neovascularization in ischemic myocardium but did not show a functional regenerative effect.
    von Wattenwyl R; Blumenthal B; Heilmann C; Golsong P; Poppe A; Beyersdorf F; Siepe M
    ASAIO J; 2012; 58(3):268-74. PubMed ID: 22543757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of connexin43 into skeletal muscle.
    Reinecke H; Minami E; Virag JI; Murry CE
    Hum Gene Ther; 2004 Jul; 15(7):627-36. PubMed ID: 15242523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel hyperbranched polyamidoamine nanoparticles for transfecting skeletal myoblasts with vascular endothelial growth factor gene for cardiac repair.
    Zhu K; Guo C; Lai H; Yang W; Xia Y; Zhao D; Wang C
    J Mater Sci Mater Med; 2011 Nov; 22(11):2477-85. PubMed ID: 21870080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs and cardiac pathology.
    Latronico MV; Condorelli G
    Nat Rev Cardiol; 2009 Jun; 6(6):419-29. PubMed ID: 19434076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulating myocyte cell cycle control for cardiac repair.
    Gorr TA; Deten A
    Cardiovasc Res; 2008 Nov; 80(2):161-2. PubMed ID: 18779229
    [No Abstract]   [Full Text] [Related]  

  • 18. Skeletal myoblasts as a therapeutic agent.
    Menasché P
    Prog Cardiovasc Dis; 2007; 50(1):7-17. PubMed ID: 17631434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified mRNA as a Therapeutic Tool for the Heart.
    Kaur K; Zangi L
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):871-880. PubMed ID: 32822006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the second generation of skeletal myoblasts?
    Menasché P
    Cardiovasc Res; 2008 Aug; 79(3):355-6. PubMed ID: 18508855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.